GSK-faces-criminal-investigation-in-Poland
GSK faces criminal investigation in Poland
UK drugmaker GSK is facing aq criminal investigation in Poland. According to a step-back sales director Polnish bribing doctors were made to promote an asthma drug, Seretide for "financial gains"....
Tags: Seretide, asthma drug, doctors, sales, poland, GSK, scandal...
April 19, 2014
GlaxoSmithKline-and-MD-Anderson-entered-a-cancer-drug-alliance
GlaxoSmithKline and MD Anderson entered a cancer-drug alliance
Anderson Cancer Center of Texas University and GlaxoSmithKline announced that they are going to co-operate in further cancer research. The research for immunotherapy is going to be the part of MD Anderson’s Moon Shots Program....
Tags: MD Anderson’s Moon Shots Program, Moon Shots program, drug cancer, immunotherapy, drug research, drug development, pharmaceutical companies, GlaxoSmithKline...
April 12, 2014
Amgen-wont-collaborate-with-GSK-on-Prolia
Amgen won't collaborate with GSK on Prolia
Amgen announced that the company is goint to step back from collaborating with GSK. The two pharmaceutical giants have signed an contract and GSK commercialized the osteoporosis drug of Amgen However, amgen does not want ot contribute woth GlaxoSmithKline anymore....
Tags: GlaxoSimithKline, GSK, Prolia, osteoporosis, amgen...
April 9, 2014
EMA-and-TGA-collaborate-to-find-new-orphan-drugs
EMA and TGA collaborate to find new orphan drugs
The European Medicines Agency and Australian Therapeutic Goods Administration announced that they are going to contribute on developing new orphan drugs and push them to clon...
Tags: European Medicines Agency, Australian Therapeutic Goods Administration, EMA, ...
April 9, 2014
Second-agreement-between-FORMA-and-Celgene
Second agreement between FORMA and Celgene
FORMA Therapeutics announced that its is going to ollaborate with Celgene Pharmaceuticals. The contract states that Celgene can use FORMA's platforms to develop new drugs. ...
Tags: Forma Pharmaceuitcals, drug development, celgene, contribution, pharmaceutical companies, pharmaceutical contribution...
April 4, 2014
Novozymes-announced-that-its-Veltis-is-going-t-be-used-by-GSK
Novozymes announced that its "Veltis' is going t be used by GSK
Novonenzymes announced that GSK can use its "Veltis", a half-life extension technology for Eperzan, the recently accepted drug of the company. ...
Tags: Veltis, GKS, Novozymes, extension, drug discovery, Eperzan, diabetes, type 2 diabetes...
April 4, 2014
NeoStem-acquires-California-Stem-Cell
NeoStem acquires California Stem Cell
Neostem has announced that the company is entering a definitive agreement with one of the Irvine companiey. California Stem Cell is going to co-work with NeoStem on a phase 3 clinical trial frug....
Tags: neostem, stem cell, stem cell therapy...
April 17, 2014
Novartis-has-named-the-new-leaders-of-Alcon-and-Sandoz
Novartis has named the new leaders of Alcon and Sandoz
These new leaders will set the direction for the next phase of growth for our eye care and generics businesses, two of our core growth engines....
Tags: biosimilars, pharmaceutical business, pharma leaders, novartis, alcon, sandoz, drug, drug ceo, Chutes and Ladders, Novartis, Sandoz, ...
April 12, 2014
Spero-starts-a-new-figth-against-resistant-bacteria
Spero starts a new figth against resistant bacteria
Spero has entered into a partnership with Roche based on antibiotics. The research aims to find a new treatment for resisitant bacterial infections. ...
Tags: spero. antibiotics, partnership, Roche, drugs, drug development...
April 9, 2014
Eli-Lillys-lung-cancer-drug-is-protected-by-the-court
Eli Lilly's lung cancer drug is protected by the court
federal court decided to protect Lilly's experimental cacer drug from its generic version.The drug is going to be protected till 2022....
Tags: drug; discovery; development; patent protection; Eli Lilly; Alimta; lung cancer...
April 4, 2014
Pharmaceutical-companies-team-up-to-deal-with-big-data-challenge
Pharmaceutical companies team up to deal with "big data challenge"
Cancer Research UK says it teams up with other oharmaceutical and technical companies to solve the big data problems. huge amounts of DATA received from studies is going to be analyzed now....
Tags: DATA, analisys, study, big data, cancer research, big data cancer research, Cancer research UK...
April 4, 2014
Particle-Sciences-signs-joint-development-with-Actavis
Particle Sciences signs joint development with Actavis
Particle Sciences has signed a contract with Actavis. The company is going to be responsible for the design and formulation of cGMP supplies of the pharmacutical company. ...
Tags: generic drugs, generic drug news, Actavis, Particle Scinences, pharmaceutical partnership...
April 4, 2014
MOST VIEWED

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013